Hypertension prevalence in the All of Us Research Program among groups traditionally underrepresented in medical research

Abstract The All of Us Research Program was designed to enable broad-based precision medicine research in a cohort of unprecedented scale and diversity. Hypertension (HTN) is a major public health concern. The validity of HTN data and definition of hypertension cases in the All of Us (AoU) Research...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Paulette D. Chandler, Cheryl R. Clark, Guohai Zhou, Nyia L. Noel, Confidence Achilike, Lizette Mendez, Andrea H. Ramirez, Roxana Loperena-Cortes, Kelsey Mayo, Elizabeth Cohn, Lucila Ohno-Machado, Eric Boerwinkle, Mine Cicek, Jun Qian, Sheri Schully, Francis Ratsimbazafy, Stephen Mockrin, Kelly Gebo, Julien J. Dedier, Shawn N. Murphy, Jordan W. Smoller, Elizabeth W. Karlson, the All of Us Research Program Investigators
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/46937ed79fb4451397e12dd210cbf27a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:46937ed79fb4451397e12dd210cbf27a
record_format dspace
spelling oai:doaj.org-article:46937ed79fb4451397e12dd210cbf27a2021-12-02T17:45:02ZHypertension prevalence in the All of Us Research Program among groups traditionally underrepresented in medical research10.1038/s41598-021-92143-w2045-2322https://doaj.org/article/46937ed79fb4451397e12dd210cbf27a2021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-92143-whttps://doaj.org/toc/2045-2322Abstract The All of Us Research Program was designed to enable broad-based precision medicine research in a cohort of unprecedented scale and diversity. Hypertension (HTN) is a major public health concern. The validity of HTN data and definition of hypertension cases in the All of Us (AoU) Research Program for use in rule-based algorithms is unknown. In this cross-sectional, population-based study, we compare HTN prevalence in the AoU Research Program to HTN prevalence in the 2015–2016 National Health and Nutrition Examination Survey (NHANES). We used AoU baseline data from patient (age ≥ 18) measurements (PM), surveys, and electronic health record (EHR) blood pressure measurements. We retrospectively examined the prevalence of HTN in the EHR cohort using Systemized Nomenclature of Medicine (SNOMED) codes and blood pressure medications recorded in the EHR. We defined HTN as the participant having at least 2 HTN diagnosis/billing codes on separate dates in the EHR data AND at least one HTN medication. We calculated an age-standardized HTN prevalence according to the age distribution of the U.S. Census, using 3 groups (18–39, 40–59, and ≥ 60). Among the 185,770 participants enrolled in the AoU Cohort (mean age at enrollment = 51.2 years) available in a Researcher Workbench as of October 2019, EHR data was available for at least one SNOMED code from 112,805 participants, medications for 104,230 participants, and 103,490 participants had both medication and SNOMED data. The total number of persons with SNOMED codes on at least two distinct dates and at least one antihypertensive medication was 33,310 for a crude prevalence of HTN of 32.2%. AoU age-adjusted HTN prevalence was 27.9% using 3 groups compared to 29.6% in NHANES. The AoU cohort is a growing source of diverse longitudinal data to study hypertension nationwide and develop precision rule-based algorithms for use in hypertension treatment and prevention research. The prevalence of hypertension in this cohort is similar to that in prior population-based surveys.Paulette D. ChandlerCheryl R. ClarkGuohai ZhouNyia L. NoelConfidence AchilikeLizette MendezAndrea H. RamirezRoxana Loperena-CortesKelsey MayoElizabeth CohnLucila Ohno-MachadoEric BoerwinkleMine CicekJun QianSheri SchullyFrancis RatsimbazafyStephen MockrinKelly GeboJulien J. DedierShawn N. MurphyJordan W. SmollerElizabeth W. Karlsonthe All of Us Research Program InvestigatorsNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Paulette D. Chandler
Cheryl R. Clark
Guohai Zhou
Nyia L. Noel
Confidence Achilike
Lizette Mendez
Andrea H. Ramirez
Roxana Loperena-Cortes
Kelsey Mayo
Elizabeth Cohn
Lucila Ohno-Machado
Eric Boerwinkle
Mine Cicek
Jun Qian
Sheri Schully
Francis Ratsimbazafy
Stephen Mockrin
Kelly Gebo
Julien J. Dedier
Shawn N. Murphy
Jordan W. Smoller
Elizabeth W. Karlson
the All of Us Research Program Investigators
Hypertension prevalence in the All of Us Research Program among groups traditionally underrepresented in medical research
description Abstract The All of Us Research Program was designed to enable broad-based precision medicine research in a cohort of unprecedented scale and diversity. Hypertension (HTN) is a major public health concern. The validity of HTN data and definition of hypertension cases in the All of Us (AoU) Research Program for use in rule-based algorithms is unknown. In this cross-sectional, population-based study, we compare HTN prevalence in the AoU Research Program to HTN prevalence in the 2015–2016 National Health and Nutrition Examination Survey (NHANES). We used AoU baseline data from patient (age ≥ 18) measurements (PM), surveys, and electronic health record (EHR) blood pressure measurements. We retrospectively examined the prevalence of HTN in the EHR cohort using Systemized Nomenclature of Medicine (SNOMED) codes and blood pressure medications recorded in the EHR. We defined HTN as the participant having at least 2 HTN diagnosis/billing codes on separate dates in the EHR data AND at least one HTN medication. We calculated an age-standardized HTN prevalence according to the age distribution of the U.S. Census, using 3 groups (18–39, 40–59, and ≥ 60). Among the 185,770 participants enrolled in the AoU Cohort (mean age at enrollment = 51.2 years) available in a Researcher Workbench as of October 2019, EHR data was available for at least one SNOMED code from 112,805 participants, medications for 104,230 participants, and 103,490 participants had both medication and SNOMED data. The total number of persons with SNOMED codes on at least two distinct dates and at least one antihypertensive medication was 33,310 for a crude prevalence of HTN of 32.2%. AoU age-adjusted HTN prevalence was 27.9% using 3 groups compared to 29.6% in NHANES. The AoU cohort is a growing source of diverse longitudinal data to study hypertension nationwide and develop precision rule-based algorithms for use in hypertension treatment and prevention research. The prevalence of hypertension in this cohort is similar to that in prior population-based surveys.
format article
author Paulette D. Chandler
Cheryl R. Clark
Guohai Zhou
Nyia L. Noel
Confidence Achilike
Lizette Mendez
Andrea H. Ramirez
Roxana Loperena-Cortes
Kelsey Mayo
Elizabeth Cohn
Lucila Ohno-Machado
Eric Boerwinkle
Mine Cicek
Jun Qian
Sheri Schully
Francis Ratsimbazafy
Stephen Mockrin
Kelly Gebo
Julien J. Dedier
Shawn N. Murphy
Jordan W. Smoller
Elizabeth W. Karlson
the All of Us Research Program Investigators
author_facet Paulette D. Chandler
Cheryl R. Clark
Guohai Zhou
Nyia L. Noel
Confidence Achilike
Lizette Mendez
Andrea H. Ramirez
Roxana Loperena-Cortes
Kelsey Mayo
Elizabeth Cohn
Lucila Ohno-Machado
Eric Boerwinkle
Mine Cicek
Jun Qian
Sheri Schully
Francis Ratsimbazafy
Stephen Mockrin
Kelly Gebo
Julien J. Dedier
Shawn N. Murphy
Jordan W. Smoller
Elizabeth W. Karlson
the All of Us Research Program Investigators
author_sort Paulette D. Chandler
title Hypertension prevalence in the All of Us Research Program among groups traditionally underrepresented in medical research
title_short Hypertension prevalence in the All of Us Research Program among groups traditionally underrepresented in medical research
title_full Hypertension prevalence in the All of Us Research Program among groups traditionally underrepresented in medical research
title_fullStr Hypertension prevalence in the All of Us Research Program among groups traditionally underrepresented in medical research
title_full_unstemmed Hypertension prevalence in the All of Us Research Program among groups traditionally underrepresented in medical research
title_sort hypertension prevalence in the all of us research program among groups traditionally underrepresented in medical research
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/46937ed79fb4451397e12dd210cbf27a
work_keys_str_mv AT paulettedchandler hypertensionprevalenceintheallofusresearchprogramamonggroupstraditionallyunderrepresentedinmedicalresearch
AT cherylrclark hypertensionprevalenceintheallofusresearchprogramamonggroupstraditionallyunderrepresentedinmedicalresearch
AT guohaizhou hypertensionprevalenceintheallofusresearchprogramamonggroupstraditionallyunderrepresentedinmedicalresearch
AT nyialnoel hypertensionprevalenceintheallofusresearchprogramamonggroupstraditionallyunderrepresentedinmedicalresearch
AT confidenceachilike hypertensionprevalenceintheallofusresearchprogramamonggroupstraditionallyunderrepresentedinmedicalresearch
AT lizettemendez hypertensionprevalenceintheallofusresearchprogramamonggroupstraditionallyunderrepresentedinmedicalresearch
AT andreahramirez hypertensionprevalenceintheallofusresearchprogramamonggroupstraditionallyunderrepresentedinmedicalresearch
AT roxanaloperenacortes hypertensionprevalenceintheallofusresearchprogramamonggroupstraditionallyunderrepresentedinmedicalresearch
AT kelseymayo hypertensionprevalenceintheallofusresearchprogramamonggroupstraditionallyunderrepresentedinmedicalresearch
AT elizabethcohn hypertensionprevalenceintheallofusresearchprogramamonggroupstraditionallyunderrepresentedinmedicalresearch
AT lucilaohnomachado hypertensionprevalenceintheallofusresearchprogramamonggroupstraditionallyunderrepresentedinmedicalresearch
AT ericboerwinkle hypertensionprevalenceintheallofusresearchprogramamonggroupstraditionallyunderrepresentedinmedicalresearch
AT minecicek hypertensionprevalenceintheallofusresearchprogramamonggroupstraditionallyunderrepresentedinmedicalresearch
AT junqian hypertensionprevalenceintheallofusresearchprogramamonggroupstraditionallyunderrepresentedinmedicalresearch
AT sherischully hypertensionprevalenceintheallofusresearchprogramamonggroupstraditionallyunderrepresentedinmedicalresearch
AT francisratsimbazafy hypertensionprevalenceintheallofusresearchprogramamonggroupstraditionallyunderrepresentedinmedicalresearch
AT stephenmockrin hypertensionprevalenceintheallofusresearchprogramamonggroupstraditionallyunderrepresentedinmedicalresearch
AT kellygebo hypertensionprevalenceintheallofusresearchprogramamonggroupstraditionallyunderrepresentedinmedicalresearch
AT julienjdedier hypertensionprevalenceintheallofusresearchprogramamonggroupstraditionallyunderrepresentedinmedicalresearch
AT shawnnmurphy hypertensionprevalenceintheallofusresearchprogramamonggroupstraditionallyunderrepresentedinmedicalresearch
AT jordanwsmoller hypertensionprevalenceintheallofusresearchprogramamonggroupstraditionallyunderrepresentedinmedicalresearch
AT elizabethwkarlson hypertensionprevalenceintheallofusresearchprogramamonggroupstraditionallyunderrepresentedinmedicalresearch
AT theallofusresearchprograminvestigators hypertensionprevalenceintheallofusresearchprogramamonggroupstraditionallyunderrepresentedinmedicalresearch
_version_ 1718379582757797888